The PH domain proteins IPIP27A and B link OCRL1 to receptor recycling in the endocytic pathway

Molecular Biology of the Cell

Volumn 22, Issue 5, 2011, Pages 606-623

  Noakes, Christopher J ^a   Lee, Grace ^a,b   Lowe, Martin ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LS9 Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; INOSITOL POLYPHOSPHATE PHOSPHATASE INTERACTING PROTEIN 27 A; INOSITOL POLYPHOSPHATE PHOSPHATASE INTERACTING PROTEIN 27 B; SYNAPTOJANIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DENT DISEASE; DISEASE ASSOCIATION; ENDOSOME; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LOWE SYNDROME; MISSENSE MUTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANS GOLGI NETWORK;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL MEMBRANE; CONSERVED SEQUENCE; ENDOCYTOSIS; ENDOSOMES; HELA CELLS; HUMANS; HYDROLASES; LYSOSOMES; MOLECULAR SEQUENCE DATA; MUTATION; OCULOCEREBRORENAL SYNDROME; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, TRANSFERRIN; RNA, SMALL INTERFERING; SECRETORY PATHWAY; SHIGA TOXIN; TRANS-GOLGI NETWORK; VESICULAR TRANSPORT PROTEINS;

EID: 79952345977     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-08-0730     Document Type: Article

References (55)

1. Attree O, Olivos IM, Okabe I, Bailey LC, Nelson DL, Lewis RA, McInnes RR, Nussbaum RL (1992). The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358, 239-242.
2. Balla T (2005). Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J Cell Sci 118, 2093-2104.
3. Balla T, Szentpetery Z, Kim YJ (2009). Phosphoinositide signaling: new tools and insights. Physiology (Bethesda) 24, 231-244.
4. Behnia R, Munro S (2005). Organelle identity and the signposts for membrane traffic. Nature 438, 597-604. (Pubitemid 41740563)
5. Bonifacino JS, Rojas R (2006). Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol 7, 568-579. (Pubitemid 44325348)
6. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG (2001). Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J Cell Biol 154, 1007-1017. (Pubitemid 34286180)
7. Choudhury R et al. (2005). Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell 16, 3467-3479. (Pubitemid 41077061)
8. Choudhury R, Noakes CJ, McKenzie E, Kox C, Lowe M (2009). Differential clathrin binding and subcellular localization of OCRL1 splice isoforms. J Biol Chem 284, 9965-9973.
9. Christensen EI, Birn H (2002). Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3, 256-266. (Pubitemid 34619261)
10. Christensen EI, Devuyst O, Dom G, Nielsen R, Van Der Smissen P, Verroust P, Leruth M, Guggino WB, Courtoy PJ (2003). Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci USA 100, 8472-8477. (Pubitemid 36842569)
11. Coon BG, Mukherjee D, Hanna CB, Riese DJ 2nd, Lowe M, Aguilar RC (2009). Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase. Hum Mol Genet 18, 4478-4491.
12. Cui S, Guerriero CJ, Szalinski CM, Kinlough CL, Hughey RP, Weisz OA (2010). OCRL1 function in renal epithelial membrane traffic. Am J Physiol Renal Physiol 298, F335-F345.
13. Davidson HW (1995). Wortmannin causes mistargeting of procathepsin D. Evidence for the involvement of a phosphatidylinositol 3-kinase in vesicular transport to lysosomes. J Cell Biol 130, 797-805.
14. Di Paolo G, De Camilli P (2006). Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657. (Pubitemid 44564702)
15. Diao A, Rahman D, Pappin DJ, Lucocq J, Lowe M (2003). The coiled-coil membrane protein golgin-84 is a novel rab effector required for Golgi ribbon formation. J Cell Biol 160, 201-212. (Pubitemid 36254954)
16. Erdmann KS, Mao Y, McCrea HJ, Zoncu R, Lee S, Paradise S, Modregger J, Biemesderfer D, Toomre D, De Camilli P (2007). A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev Cell 13, 377-390. (Pubitemid 47321603)
17. Faucherre A, Desbois P, Nagano F, Satre V, Lunardi J, Gacon G, Dorseuil O (2005). Lowe syndrome protein Ocrl1 is translocated to membrane ruffles upon Rac GTPase activation: a new perspective on Lowe syndrome pathophysiology. Hum Mol Genet 14, 1441-1448. (Pubitemid 40823454)
18. Faucherre A, Desbois P, Satre V, Lunardi J, Dorseuil O, Gacon G (2003). Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network. Hum Mol Genet 12, 2449-2456. (Pubitemid 37220409)
19. Fraldi A et al. (2010). Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders. EMBO J 29, 3607-3620.
20. Fukuda M, Kanno E, Ishibashi K, Itoh T (2008). Large scale screening for novel rab effectors reveals unexpected broad Rab binding specificity. Mol Cell Proteomics 7, 1031-1042. (Pubitemid 351943951)
21. Giot L et al. (2003). A protein interaction map of Drosophila melanogaster. Science 302, 1727-1736. (Pubitemid 37505730)
22. Grant BD, Donaldson JG (2009). Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol 10, 597-608.
23. Hoopes RR Jr et al. (2005). Dent Disease with mutations in OCRL1. Am J Hum Genet 76, 260-267.
24. Hsu VW, Prekeris R (2010). Transport at the recycling endosome. Curr Opin Cell Biol 22, 528-534.
25. Hyvola N, Diao A, McKenzie E, Skippen A, Cockcroft S, Lowe M (2006). Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases. EMBO J 25, 3750-3761. (Pubitemid 44300261)
26. Janne PA, Suchy SF, Bernard D, MacDonald M, Crawley J, Grinberg A, Wynshaw-Boris A, Westphal H, Nussbaum RL (1998). Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J Clin Invest 101, 2042-2053. (Pubitemid 28244088)
27. Jefferson AB, Majerus PW (1996). Mutation of the conserved domains of two inositol polyphosphate 5-phosphatases. Biochemistry 35, 7890-7894.
28. Johannes L, Popoff V (2008). Tracing the retrograde route in protein trafficking. Cell 135, 1175-1187.
29. Jovic M, Kieken F, Naslavsky N, Sorgen PL, Caplan S (2009). Eps15 homo-logy domain 1-associated tubules contain phosphatidylinositol-4-phosphate and phosphatidylinositol-(4,5)-bisphosphate and are required for efficient recycling. Mol Biol Cell 20, 2731-2743.
30. Karageorgos LE, Isaac EL, Brooks DA, Ravenscroft EM, Davey R, Hopwood JJ, Meikle PJ (1997). Lysosomal biogenesis in lysosomal storage disorders. Exp Cell Res 234, 85-97. (Pubitemid 27317905)
31. Lemmon MA (2008). Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 9, 99-111.
32. Lowe M (2005). Structure and function of the Lowe syndrome protein OCRL1. Traffic 6, 711-719.
33. Mao Y, Balkin DM, Zoncu R, Erdmann KS, Tomasini L, Hu F, Jin MM, Hodsdon ME, De Camilli P (2009). A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism. EMBO J 28, 1831-1842.
34. Matzaris M, Jackson SP, Laxminarayan KM, Speed CJ, Mitchell CA (1994). Identification and characterization of the phosphatidylinositol-(4, 5)-bisphosphate 5-phosphatase in human platelets. J Biol Chem 269, 3397-3402.
35. McCrea HJ, De Camilli P (2009). Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology (Bethesda) 24, 8-16.
36. Miaczynska M, Christoforidis S, Giner A, Shevchenko A, Uttenweiler-Joseph S, Habermann B, Wilm M, Parton RG, Zerial M (2004). APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116, 445-456. (Pubitemid 38366320)
37. Mills IG, Praefcke GJ, Vallis Y, Peter BJ, Olesen LE, Gallop JL, Butler PJ, Evans PR, McMahon HT (2003). EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking. J Cell Biol 160, 213-222. (Pubitemid 36254955)
38. Norden AG et al. (2002). Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. J Am Soc Nephrol 13, 125-133. (Pubitemid 34042019)
39. Nussbaum R, Suchy SF (2001). Lowe syndrome. In: Metabolic and molecular basis of inherited diseases, vol IV, ed. CR Scriver AL Beauder, WS Sly, D Valle, New York: McGraw-Hill, 6257-6266.
40. Olivos-Glander IM, Janne PA, Nussbaum RL (1995). The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex. Am J Hum Genet 57, 817-823.
41. Parkinson-Lawrence EJ, Shandala T, Prodoehl M, Plew R, Borlace GN, Brooks DA (2010). Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda) 25, 102-115.
42. Saint-Pol A et al. (2004). Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev Cell 6, 525-538. (Pubitemid 38456181)
43. Schmid AC, Wise HM, Mitchell CA, Nussbaum R, Woscholski R (2004). Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation. FEBS Lett 576, 9-13. (Pubitemid 39330448)
44. Schurman SJ, Scheinman SJ (2009). Inherited cerebrorenal syndromes. Nat Rev Nephrol 5, 529-538.
45. Seaman MN (2004). Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J Cell Biol 165, 111-122.
46. Shin HW et al. (2005). An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J Cell Biol 170, 607-618.
47. Suchy SF, Cronin JC, Nussbaum RL (2009). Abnormal bradykinin signaling in fibroblasts deficient in the PIP(2) 5-phosphatase, ocrl1. J Inherit Metab Dis 32, 280-288.
48. Suchy SF, Nussbaum RL (2002). The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization. Am J Hum Genet 71, 1420-1427. (Pubitemid 36015895)
49. Swan LE, Tomasini L, Pirruccello M, Lunardi J, De Camilli P (2010). Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1. Proc Natl Acad Sci USA 107, 3511-3516.
50. Ungewickell A, Ward ME, Ungewickell E, Majerus PW (2004). The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin. Proc Natl Acad Sci USA 101, 13501-13506. (Pubitemid 39238432)
51. Ungewickell AJ, Majerus PW (1999). Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome. Proc Natl Acad Sci USA 96, 13342-13344.
52. Vicinanza M, D'Angelo G, Di Campli A, De Matteis MA (2008). Phosphoinositides as regulators of membrane trafficking in health and disease. Cell Mol Life Sci 65, 2833-2841.
53. Williams C, Choudhury R, McKenzie E, Lowe M (2007). Targeting of the type II inositol polyphosphate 5-phosphatase INPP5B to the early secretory pathway. J Cell Sci 120, 3941-3951. (Pubitemid 350269400)
54. Zimmermann P, Zhang Z, Degeest G, Mortier E, Leenaerts I, Coomans C, Schulz J, N'Kuli F, Courtoy PJ, David G (2005). Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6. Dev Cell 9, 377-388. (Pubitemid 41235807)
55. Zoncu R, Perera RM, Balkin DM, Pirruccello M, Toomre D, De Camilli P (2009). A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell 136, 1110-1121.